Published on
August 5, 2026
- 22:30 GMT
The Lancet’s eClinicalMedicine Publishes Phase I Data for SPVX02, a Fridge-free Td Vaccine Stable for 24 Months at 30°C
Stablepharma announce Phase 1 clinical trial results for SPVX02, a thermostable reformulation of a licensed Td vaccine, published in the eClinicalMedicine LONDON, ENG, UNITED KINGDOM, August 5, 2026 /EINPresswire.com/ -- Stablepharma Limited today …
Distribution channels:
Environment, Healthcare & Pharmaceuticals Industry
...
